Post-marketing studies of new insulins: sales or science?
Diabetes and Metabolism, Learning and Research, Southmead Hospital, Bristol BS10 5NB, UK. Edwin.Gale@bristol.ac.uk
Edwin A M
EA
Gale
D017327:Clinical Trials, Phase IV as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004345:Drug Industry / Q000191:economics*; D057915:Drug Substitution / Q000191:economics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use; D007328:Insulin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D040541:Marketing / Q000191:economics; D015337:Multicenter Studies as Topic; D011358:Product Surveillance, Postmarketing / Q000191:economics* / Q000379:methods
D007004:Hypoglycemic Agents; D007328:Insulin